A Powerhouse Firm When You Want a Deep Understanding of IP Law.

Chambers & Partners

Trial Win

$83.4 Million Verdict for TwinStrand Biosciences, Inc.

Ranking

Sterne Kessler Recognized for Patent Litigation and Prosecution

2024 LMG Life Sciences

Ranking

Sterne Kessler Ranked Best Performing Law Firm for Appellees

Patexia 2024 CAFC Intelligence Report

Firm News November 19, 2024
Sterne Kessler Secures U.S. International Trade Commission Win for SV3 in Unfair Importation Case Brought by RJ Reynolds

Sterne Kessler Secures U.S. International Trade Commission Win for SV3 in Unfair Importation Case Brought by RJ Reynolds

Washington, D.C. (November 19, 2024) – Sterne, Kessler, Goldstein & Fox received a significant ruling in a patent infringement case before the U.S. International Trade Commission (ITC) on…

Learn more about Sterne Kessler Secures U.S. International Trade Commission Win for SV3 in Unfair Importation Case Brought by RJ Reynolds
Firm News November 7, 2024
Sterne Kessler Secures PTAB Victory for Palo Alto Networks against British Telecommunications—All Claims Unpatentable

Sterne Kessler Secures PTAB Victory for Palo Alto Networks against British Telecommunications—All Claims Unpatentable

Sterne, Kessler, Goldstein & Fox secured a final written decision finding all claims unpatentable in an inter partes review at the U.S. Patent and Trademark Office Patent Trial…

Learn more about Sterne Kessler Secures PTAB Victory for Palo Alto Networks against British Telecommunications—All Claims Unpatentable
Articles October 17, 2024
Old Drugs, New Tricks: Repurposing Through 505(b)(2) Submissions

Old Drugs, New Tricks: Repurposing Through 505(b)(2) Submissions

Summer Associates Hannah Jankunis and Matthew Swazer also contributed to this article.  FDA DRUG APPROVAL PATHWAYS 505(b)(1) New Drug Application De novo drug development is costly and time…

Learn more about Old Drugs, New Tricks: Repurposing Through 505(b)(2) Submissions
Articles October 14, 2024
Subject Matter Eligibility of AI Innovations—USPTO’s Updated Guidance

Subject Matter Eligibility of AI Innovations—USPTO’s Updated Guidance

This article discusses the July 17, 2024 guidance[1] issued by the United States Patent and Trademark Office (“USPTO”) regarding the subject matter eligibility of patent claims involving artificial…

Learn more about Subject Matter Eligibility of AI Innovations—USPTO’s Updated Guidance
Articles October 9, 2024
A Look at the PTAB’s Assessment of Prior Art Exceptions

A Look at the PTAB’s Assessment of Prior Art Exceptions

Under the Leahy-Smith America Invents Act, Title 35 of the U.S. Code, Section 102(a), prior art is determined based on the effective filing date of the claimed invention,…

Learn more about A Look at the PTAB’s Assessment of Prior Art Exceptions
Firm News October 2, 2024
Sterne Kessler Achieves Mansfield Rule Certification for 2023-24

Sterne Kessler Achieves Mansfield Rule Certification for 2023-24

Washington, D.C. (October 2, 2024) – Sterne, Kessler, Goldstein & Fox is proud to announce that the firm has earned Mansfield Certification for 2023-2024. This accomplishment underscores the…

Learn more about Sterne Kessler Achieves Mansfield Rule Certification for 2023-24

Your innovations are worth the best protection

As one of the largest and most diverse intellectual property firms in the United States, Sterne Kessler has the experience to handle your most complex IP challenges. From litigation to patent and trademark prosecution, practicing at the Patent Trial and Appeal Board, and general IP strategy, we have the right team for your needs.
Find a Professional
View All Professionals

Find by Last Name

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Expertise

Sterne Kessler is a full-service IP firm that delivers innovative solutions tailored to your business and industry.